Laos vs Togo: Treatment coverage for schistosomiasis
Laos
82.9%
in 2024
Togo
86.0%
in 2024
Laos rank
8th
Togo rank
6th
Treatment coverage for schistosomiasis over time
- Laos
- Togo
How they compare
Togo currently reports 86.0% against 82.9% in Laos, a difference of 3.1%.
The two have swapped places 5 times across 13 shared years of data; in 2010 it was Laos ahead.
Laos ranks 8th and Togo ranks 6th of 45 countries.
Laos has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Laos | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.7% | 62.6% | 24.1% | Laos |
| 2020s | 81.0% | 58.7% | 22.3% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Laos or Togo?
- Togo, at 86.0% against 82.9% in Laos as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Laos and Togo?
- 3.1%, with Togo ahead.
- How many years of comparable data are there for Laos and Togo?
- 13 years are reported by both, from 2010 to 2024.
- How do Laos and Togo rank globally for treatment coverage for schistosomiasis?
- Laos ranks 8th and Togo ranks 6th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.